Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Allergan's Price Reform Pledge: Will Others Follow?

Executive Summary

Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.


Related Content

Saunders: Industry Must Act Before We Lose Champions For Innovation In Congress
Under Pressure: Sanofi Joins Call For Price Transparency
PhRMA Uses Allergan Stage In Campaign To Keep Focus On Industry's Reputation For Innovation
Allergan Confident About Continued Growth, Swats Down Competition Concerns
The New World Of Pharma – Markets, Messaging And The Flash Mob
Pharma Strategizes On Drug Pricing On Day One Of J.P. Morgan
What Does 2017 Hold For Pharma?
Clinton's Plan To Tame 'Unjustified' Drug Prices: Who's At Risk?
More Than 'That Old Shkreli Co.,' KaloBios Ready To Innovate, Change Biotech
EpiPen's Swollen Price May Trigger Patient Assistance Program Probes


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts